This is a US news story, published by Wired, that relates primarily to RSV news.
For more US news, you can click here:
more US newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Wired, you can click here:
more news from WiredOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
RSV vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccine safety concerns news, vaccine news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
RSV vaccinesWired
•
80% Informative
RSV vaccines hold the potential to reduce the thousands of hospitalizations and deaths associated with the virus in the US each year .
So far this year only 19 percent of Hispanic people in this age group have been vaccinated, compared to 35 percent of white, 31 percent of Asian , and 24 percent of Black seniors.
VR Score
85
Informative language
90
Neutral language
61
Article tone
semi-formal
Language
English
Language complexity
64
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Source diversity
4
Affiliate links
no affiliate links